APA (7th ed.) Citation

Li, L., Zhang, S., Xie, D., Chen, H., Zheng, X., & Pan, D. (2018). Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy. OncoTargets & Therapy, 11, 6111. https://doi.org/10.2147/OTT.S172957

Chicago Style (17th ed.) Citation

Li, Liangqing, Shengwei Zhang, Diya Xie, Hui Chen, Xuelan Zheng, and Dun Pan. "Dual Inhibitor of PI3K and MTOR (NVP-BEZ235) Augments the Efficacy of Fluorouracil on Gastric Cancer Chemotherapy." OncoTargets & Therapy 11 (2018): 6111. https://doi.org/10.2147/OTT.S172957.

MLA (9th ed.) Citation

Li, Liangqing, et al. "Dual Inhibitor of PI3K and MTOR (NVP-BEZ235) Augments the Efficacy of Fluorouracil on Gastric Cancer Chemotherapy." OncoTargets & Therapy, vol. 11, 2018, p. 6111, https://doi.org/10.2147/OTT.S172957.